With a team of approximately 7,500 employees and operations in nearly 40 countries, we are a global biopharmaceutical company investing about a quarter of our revenue in cutting-edge scientific research to meet unmet patient needs. Global headquarters are in Brussels, Belgium, with U.S. headquarters in Atlanta, Georgia. Additional U.S. sites include global clinical development in Raleigh, North Carolina, our policy office in Washington, D.C., and research supporting UCB’s pipeline in Boston, Massachusetts and Seattle, Washington. We also have an office in Durham, North Carolina as part of our acquisition of Element Genomics.
While UCB offices throughout the country work to discover and develop innovative therapies, UCB’s Atlanta office focuses on the delivery of those medicines – ensuring patients, caregivers, and their doctors or healthcare providers are supported and can access our solutions.